FDA Inspection
Suresh RamalingamSuresh Ramalingam – FDA Inspection, Oct 7, 2010
Record Details
This FDA Inspection record concerns Suresh Ramalingam, with an inspection on October 7, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Suresh Ramalingam
- Inspection Date
- October 7, 2010
- Product Type
- Drugs
View Company Profile
ID · b2d853ae-2a5a-4ab5-9d8a-9a3c40d3daa3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 685823
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Suresh Ramalingam
1| Date | Classification | Office | Project area |
|---|---|---|---|
| December 17, 2010 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Suresh Ramalingam
- FDA Inspection 710675 - 2010-12-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.